JPMorgan Chase & Co’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $7.5M | Buy |
|
|||||
|
2024
Q4 | $7.96M | Sell |
|
|||||
|
2024
Q3 | $11.4M | Sell |
|
|||||
|
2024
Q2 | $9.61M | Sell |
|
|||||
|
2024
Q1 | $23.2M | Sell |
|
|||||
|
2023
Q4 | $22.2M | Sell |
|
|||||
|
2023
Q3 | $21.9M | Buy |
|
|||||
|
2023
Q2 | $30.5M | Buy |
|
|||||
|
2023
Q1 | $24.8M | Buy |
|
|||||
|
2022
Q4 | $23.7M | Sell |
|
|||||
|
2022
Q3 | $42.8M | Sell |
|
|||||
|
2022
Q2 | $51.3M | Buy |
|
|||||
|
2022
Q1 | $32.4M | Sell |
|
|||||
|
2021
Q4 | $54.1M | Buy |
|
|||||
|
2021
Q3 | $85.4M | Buy |
|
|||||
|
2021
Q2 | $64.8M | Buy |
|
|||||
|
2021
Q1 | $84.1M | Buy |
|
|||||
|
2020
Q4 | $49.4M | Buy |
|
|||||
|
2020
Q3 | $63.7M | Buy |
|
|||||
|
2020
Q2 | $60.4M | Buy |
|
|||||
|
2020
Q1 | $7.54M | Buy |
|
|||||
|
2019
Q4 | $2.19M | Buy |
|
|||||
|
2019
Q3 | $348K | Buy |
|
|||||
|
2019
Q2 | $285K | Buy |
|
|||||
|
2019
Q1 | $156K | Sell |
|
|||||
|
2018
Q4 | $148K | Buy |
|